IgA nephropathy: Correlation between pathologic findings and complement activation

REFERENCES

1. 1. Rizk DV, Maillard N, Julian BA, et al. The emerging role of complement proteins as a target for therapy in IgA nephropathy. Front Immunol. 2019;10:504.

2. 1. Ghavari AG, Kiryluk K, Choi M, et al. Genome‐wide association study identifies susceptibility loci for IgA nephropathy. Nat Genet. 2011;43:321‐327.

3. 1. Hiemstra PS, Biewenga J, Gorter A, et al. Activation of complement by human serum IgA, secretory IgA and IgA1 fragments. Mol Immunol. 1988;25:527‐533.

4. 1. Hiemstra PS, Gorter A, Stuurman ME, van Es LA, Daha MR. Activation of the alternative pathway of complement by human serum IgA. Eur J Immunol. 1987;17:321‐326.

5. 1. Roos A, Bouwman LH, van Gijlswijk‐Janssen DJ, Faber‐Krol MC, Stahl GL, Daha MR. Human IgA activates the complement system via the mannan‐binding lectin pathway. J Immunol. 2001;167:2861‐2868.

Show all 31 references